Theravance Biopharma Inc
TBPH11.100USD
+0.200+1.83%
交易中 （美东）报价延迟15分钟
555.01M总市值
亏损市盈率 TTM
关于 Theravance Biopharma Inc 公司
Theravance Biopharma, Inc. 是一家生物制药公司，主要专注于药物的开发和商业化。其产品 YUPELRI (revefenacin) 吸入溶液适用于慢性阻塞性肺病 (COPD) 患者的维持治疗。YUPELRI 是一种处方药，用于治疗 COPD，这是一种长期肺部疾病，包括慢性支气管炎、肺气肿或两者兼有。YUPELRI 是一种抗胆碱能药物，可帮助肺部气道周围的肌肉保持放松，以防止出现喘息、呼吸急促等症状。安普洛西汀是其后期研究的去甲肾上腺素再摄取抑制剂，正在开发用于治疗症状性神经源性直立性低血压。
公司简介
公司代码TBPH
公司名称Theravance Biopharma Inc
上市日期May 16, 2014
CEOMr. Rick E. Winningham
员工数量97
证券类型Ordinary Share
年结日May 16
公司地址Ugland House, South Church Street
城市GEORGE TOWN
上市交易所NASDAQ Global Market Consolidated
国家Cayman Islands
邮编KY1-1104
电话16508086000
网址https://www.theravance.com/
公司代码TBPH
上市日期May 16, 2014
CEOMr. Rick E. Winningham
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Rick E. Winningham
Mr. Rick E. Winningham
Chief Executive Officer, Director
Chief Executive Officer, Director
1.31M
-2.21%
Dr. Aine Miller
Dr. Aine Miller
Senior Vice President - Development and Head of Ireland Office
Senior Vice President - Development and Head of Ireland Office
214.99K
+0.34%
Mr. Brett A. Grimaud
Mr. Brett A. Grimaud
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
160.16K
-5.73%
Mr. Aziz Sawaf
Mr. Aziz Sawaf
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
142.13K
-6.17%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
91.20K
+13.22%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
74.20K
+16.76%
Dr. Deepika R. Pakianathan, Ph.D.
Dr. Deepika R. Pakianathan, Ph.D.
Independent Director
Independent Director
58.06K
+22.46%
Ms. Susannah Gray
Ms. Susannah Gray
Independent Chairman of the Board
Independent Chairman of the Board
42.14K
+33.82%
Mr. Jeremy T. Grant
Mr. Jeremy T. Grant
Independent Director
Independent Director
28.54K
+59.52%
Mr. Dean Jonathan (Dean) Mitchell
Mr. Dean Jonathan (Dean) Mitchell
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Rick E. Winningham
Mr. Rick E. Winningham
Chief Executive Officer, Director
Chief Executive Officer, Director
1.31M
-2.21%
Dr. Aine Miller
Dr. Aine Miller
Senior Vice President - Development and Head of Ireland Office
Senior Vice President - Development and Head of Ireland Office
214.99K
+0.34%
Mr. Brett A. Grimaud
Mr. Brett A. Grimaud
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
160.16K
-5.73%
Mr. Aziz Sawaf
Mr. Aziz Sawaf
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
142.13K
-6.17%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
91.20K
+13.22%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
74.20K
+16.76%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
U.S.
64.38M
0.00%
Europe
0.00
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Madison Avenue Partners LP
19.02%
Weiss Asset Management
14.91%
Newtyn Management, LLC
9.51%
BlackRock Institutional Trust Company, N.A.
6.07%
Irenic Capital Management LP
5.52%
Other
44.96%
持股股东
持股股东
占比
Madison Avenue Partners LP
19.02%
Weiss Asset Management
14.91%
Newtyn Management, LLC
9.51%
BlackRock Institutional Trust Company, N.A.
6.07%
Irenic Capital Management LP
5.52%
Other
44.96%
股东类型
持股股东
占比
Hedge Fund
59.93%
Investment Advisor
16.82%
Investment Advisor/Hedge Fund
11.60%
Individual Investor
4.71%
Research Firm
2.89%
Bank and Trust
0.23%
Pension Fund
0.19%
Venture Capital
0.04%
Insurance Company
0.03%
Other
3.56%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
288
48.24M
96.47%
-10.03M
2025Q1
306
49.02M
97.92%
-10.33M
2024Q4
307
49.22M
100.10%
-11.44M
2024Q3
311
50.46M
103.15%
-9.84M
2024Q2
312
51.86M
106.61%
-21.43M
2024Q1
304
56.26M
115.67%
-11.52M
2023Q4
301
56.96M
111.33%
-13.16M
2023Q3
314
59.36M
109.50%
-14.46M
2023Q2
331
61.03M
103.70%
-24.91M
2023Q1
329
68.16M
106.54%
-18.37M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Madison Avenue Partners LP
9.51M
19.02%
--
--
Mar 31, 2025
Weiss Asset Management
7.46M
14.91%
--
--
Mar 31, 2025
Newtyn Management, LLC
4.76M
9.51%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.04M
6.07%
-127.84K
-4.04%
Mar 31, 2025
Irenic Capital Management LP
2.76M
5.52%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.08M
4.16%
+77.48K
+3.87%
Mar 31, 2025
Park West Asset Management LLC
1.80M
3.61%
+11.26K
+0.63%
Mar 31, 2025
Winningham (Rick E)
1.31M
2.61%
-29.60K
-2.21%
Jun 23, 2025
Oasis Management Company Ltd.
1.12M
2.24%
+3.17K
+0.28%
Mar 31, 2025
State Street Global Advisors (US)
1.07M
2.13%
-155.69K
-12.74%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Virtus LifeSci Biotech Products ETF
2%
Invesco NASDAQ Future Gen 200 ETF
0.54%
ALPS Medical Breakthroughs ETF
0.37%
Global X Aging Population ETF
0.35%
iShares U.S. Pharmaceuticals ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.15%
iShares Micro-Cap ETF
0.09%
Invesco Nasdaq Biotechnology ETF
0.06%
ProShares Ultra Nasdaq Biotechnology
0.06%
Avantis US Small Cap Equity ETF
0.05%
查看更多
Virtus LifeSci Biotech Products ETF
占比2%
Invesco NASDAQ Future Gen 200 ETF
占比0.54%
ALPS Medical Breakthroughs ETF
占比0.37%
Global X Aging Population ETF
占比0.35%
iShares U.S. Pharmaceuticals ETF
占比0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
占比0.15%
iShares Micro-Cap ETF
占比0.09%
Invesco Nasdaq Biotechnology ETF
占比0.06%
ProShares Ultra Nasdaq Biotechnology
占比0.06%
Avantis US Small Cap Equity ETF
占比0.05%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
